Neurometrix Stock Analysis

NeuroMetrix Stock Analysis Notes

About 25.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.53. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NeuroMetrix recorded a loss per share of 4.62. The entity last dividend was issued on the 28th of March 2007. The firm had 1:8 split on the 22nd of November 2023. NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts. Neurometrix operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 23 people. To find out more about NeuroMetrix contact the company at 781 890 9989 or learn more at https://www.neurometrix.com.

NeuroMetrix Investment Alerts

NeuroMetrix Upcoming and Recent Events

NeuroMetrix Largest EPS Surprises

View All Earnings Estimates

NeuroMetrix Environmental, Social, and Governance (ESG) Scores

NeuroMetrix Stock Institutional Investors

Note, although NeuroMetrix's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

NeuroMetrix Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.68 M.

NeuroMetrix Profitablity

The company has Profit Margin (PM) of (2.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.97) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.97.

Management Efficiency

NeuroMetrix has return on total asset (ROA) of (0.2821) % which means that it has lost $0.2821 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4278) %, meaning that it created substantial loss on money invested by shareholders. NeuroMetrix's management efficiency ratios could be used to measure how well NeuroMetrix manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of November 2024, Return On Tangible Assets is likely to drop to -0.32. In addition to that, Return On Capital Employed is likely to drop to -0.37. At this time, NeuroMetrix's Non Currrent Assets Other are very stable compared to the past year. As of the 23rd of November 2024, Other Current Assets is likely to grow to about 1.5 M, while Total Assets are likely to drop about 17.5 M.

Technical Drivers

As of the 23rd of November, NeuroMetrix secures the Mean Deviation of 2.67, risk adjusted performance of 0.0759, and Downside Deviation of 3.19. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NeuroMetrix, as well as the relationship between them.

NeuroMetrix Price Movement Analysis

NeuroMetrix Insider Trading Activities

NeuroMetrix Outstanding Bonds

NeuroMetrix Predictive Daily Indicators

NeuroMetrix Corporate Filings

NeuroMetrix Forecast Models

NeuroMetrix's time-series forecasting models are one of many NeuroMetrix's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NeuroMetrix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how NeuroMetrix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NeuroMetrix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as NeuroMetrix. By using and applying NeuroMetrix Stock analysis, traders can create a robust methodology for identifying NeuroMetrix entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. NeuroMetrix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. NeuroMetrix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

NeuroMetrix stock analysis indicators help investors evaluate how NeuroMetrix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading NeuroMetrix shares will generate the highest return on investment. By understating and applying NeuroMetrix stock analysis, traders can identify NeuroMetrix position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.